ikhutch, I, like you have been a long term holder (much to my dismay). At this stage all I know is what was posted on the website back in September link http://www.progen.com.au/Docs/prs/Progen's%20PG11047%20Phase%201%20Study%20Completed.pdf
They also state that 2010 is set to be a landmark year for Progen - we expect muparfostat (formerly PI-88) registration trials to be started by our muparfostat partner Global TransBiotech, to complete the Phase 2 muparfostat trial for metastatic melanoma, to progress PG11047 to phase 2 development and to advance our angiogenesis compound, PG545, towards Phase 1 development.
Hope it reflects in the sp.
PGL Price at posting:
65.0¢ Sentiment: Hold Disclosure: Held